A Single Dose of an Inhibitor of Cyclooxygenase 2, Meloxicam, Administered Shortly after Irradiation Increases Survival of Lethally Irradiated Mice

• Autoři: HOFER M.; POSPÍŠIL M.; DUŠEK Ladislav; HOFEROVÁ Z.; WEITEROVÁ L.
• Rok publikování: 2011
• Druh: Článek v odborném periodiku
• Časopis / Zdroj: Radiation Research
• Fakulta / Pracoviště MU: Lékařská fakulta
• Doi: https://doi.org/10.1667/RR2614.1
• Obor: Biofyzika
• Klíčová slova: GAMMA-IRRADIATION; HEMATOPOIETIC RECOVERY; G-CSF; INDOMETHACIN; TOXICITY
• Popis: This study extends earlier findings of the authors demonstrating that meloxicam, a selective inhibitor of cyclooxygenase 2, supports hematopoietic recovery in sublethally irradiated mice and is radioprotective when given before irradiation. We report here that when meloxicam was administered in a single dose 1 h after a lethal 9-Gy whole-body dose, an increased 30-day survival was achieved. Additional studies showed that administration of meloxicam 24 h after lethal irradiation is ineffective and its repeated administration deleterious. Possible mechanisms of the therapeutic effects of meloxicam administered early after irradiation are discussed.

Související projekty

• Aktivace adenosinových receptorů kompbinovaná s inhibicí cyklooxygenázy v modulaci zářením vyvolavaného poškození kostní dřeně